Initial two-dose series of the Pfizer vaccine was authorized for that age group in October
Myocarditis, Pericarditis Risk Highest After Second COVID-19 Vaccine Dose
In large cohort, there were 5.55 excess events per 100,000 vaccinees after BNT162b2 and 18.39 after mRNA-1273
Natural COVID-19 Immunity Produces Protection Similar to Vaccines
Similar natural protection seen against mild and severe disease
Food Insecurity Tied to Delayed, Forgone Medical Care
Food insecurity during the pandemic disproportionately affected non-White and low-income individuals
SARS-CoV-2 Seroprevalence Up From Dec. 2021 to Feb. 2022
By February 2022, seroprevalence reached 75.2 percent among children aged 0 to 11 years, 74.2 percent for teens aged 12 to 17 years